Matt Hancock denies conflict of interest in Sir Patrick Vallance holding vaccine company shares
- Credit: PA Wire
Health secretary Matt Hancock has denied there is a conflict of interest in Sir Patrick Vallance holding £600,000 worth of shares in vaccine manufacturer GlaxoSmithKline (GSK).
Hancock said he found out from a newspaper about the UK chief scientific adviser’s shares in a drug company contracted to develop a coronavirus vaccine for the Government.
The health secretary said “any suggestion” the scientific adviser was “doing anything other than his level best to try and tackle this virus” was “wrong”.
When asked on LBC radio how he discovered the news of Vallance’s personal shareholding, Hancock said: “Well, I didn’t know about it until I read it in the newspapers.”
Pushed on whether he thought he should have been informed as health secretary, he replied: “No, not particularly. I think there are rules around this and it is important he abided by the rules.”
You may also want to watch:
He added: “The thing about the vaccine is actually the Oxford vaccine is being developed by AstraZeneca, which is one of GlaxoSmithKline’s biggest competitors, so I think if you know Sir Patrick Vallance as I do, any suggestion that he is doing anything other than his level best to try and tackle this virus is wrong.”
The UK now has access to six different Covid-19 vaccine candidates in development, with orders placed in July for 60 million doses from GSK and Sanofi Pasteur, subject to final contract.
- 1 Pro-Brexit fishing campaigner says Boris Johnson's deal has left her with 'no fish'
- 2 Nigel Farage reminded of claim that 'acid test of Brexit' surrounds fishing after clip resurfaces
- 3 European parliament agrees to add British overseas territories to post-Brexit tax haven blacklist
- 4 Ed Miliband mocks Kwasi Kwarteng's 'road to Damascus conversion'
- 5 Telegraph columnist blames Angela Merkel for Brexit
- 6 Piers Morgan causes hilarity with 'Priti Patel with a brain' jibe
- 7 Brussels to launch campaign teaching younger Britons about the EU
- 8 Backlash over Tory MP receiving Covid-19 vaccine despite not being classed as vulnerable
- 9 Boris Johnson to visit Scotland this week in attempt to shore up the union
- 10 SNP MP asks Priti Patel why she has not stood down following UK border comments
The government has also reserved up to 100 million doses of a separate vaccine being developed by Oxford University and AstraZeneca.
Sir Patrick this week said it was possible that small doses of the vaccine could be made available before the end of the year.